Calprotectin blockade inhibits long-term vascular pathology following peritoneal dialysis-associated bacterial infection

Cetin, Esra, Mazzarino, Morgane, González-Mateo, Guadalupe T., Kopytina, Valeria, Meran, Soma ORCID: https://orcid.org/0000-0003-3408-3978, Fraser, Donald ORCID: https://orcid.org/0000-0003-0102-9342, López-Cabrera, Manuel, Labéta, Mario O. ORCID: https://orcid.org/0000-0001-5750-6983 and Raby, Anne-Catherine ORCID: https://orcid.org/0000-0002-5354-5835 2023. Calprotectin blockade inhibits long-term vascular pathology following peritoneal dialysis-associated bacterial infection. Frontiers in Cellular and Infection Microbiology 13 , 1285193. 10.3389/fcimb.2023.1285193

	PDF - Supplemental Material Available under License Creative Commons Attribution. Download (678kB)
	PDF - Published Version Available under License Creative Commons Attribution. Download (2MB)

Abstract

Bacterial infections and the concurrent inflammation have been associated with increased long-term cardiovascular (CV) risk. In patients receiving peritoneal dialysis (PD), bacterial peritonitis is a common occurrence, and each episode further increases late CV mortality risk. However, the underlying mechanism(s) remains to be elucidated before safe and efficient anti-inflammatory interventions can be developed. Damage-Associated Molecular Patterns (DAMPs) have been shown to contribute to the acute inflammatory response to infections, but a potential role for DAMPs in mediating long-term vascular inflammation and CV risk following infection resolution in PD, has not been investigated. We found that bacterial peritonitis in mice that resolved within 24h led to CV disease-promoting systemic and vascular immune-mediated inflammatory responses that were maintained up to 28 days. These included higher blood proportions of inflammatory leukocytes displaying increased adhesion molecule expression, higher plasma cytokines levels, and increased aortic inflammatory and atherosclerosis-associated gene expression. These effects were also observed in infected nephropathic mice and amplified in mice routinely exposed to PD fluids. A peritonitis episode resulted in elevated plasma levels of the DAMP Calprotectin, both in PD patients and mice, here the increase was maintained up to 28 days. In vitro, the ability of culture supernatants from infected cells to promote key inflammatory and atherosclerosis-associated cellular responses, such as monocyte chemotaxis, and foam cell formation, was Calprotectin-dependent. In vivo, Calprotectin blockade robustly inhibited the short and long-term peripheral and vascular consequences of peritonitis, thereby demonstrating that targeting of the DAMP Calprotectin is a promising therapeutic strategy to reduce the long-lasting vascular inflammatory aftermath of an infection, notably PD-associated peritonitis, ultimately lowering CV risk.

Item Type:	Article
Date Type:	Published Online
Status:	Published
Schools:	Medicine
Additional Information:	License information from Publisher: LICENSE 1: URL: http://creativecommons.org/licenses/by/4.0/
Publisher:	Frontiers Media
Funders:	British Heart Foundation
Date of First Compliant Deposit:	14 December 2023
Date of Acceptance:	2 November 2023
Last Modified:	06 Jan 2024 04:20
URI:	https://orca.cardiff.ac.uk/id/eprint/164811

Actions (repository staff only)

Edit Item